The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response

Nature Medicine

Volumn 2, Issue 10, 1996, Pages 1104-1108

  Rehermann, Barbara ^a,c   Ferrari, Carlo ^b   Pasquinelli, Claudio ^a   Chisari, Francis V ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY;

ACUTE DISEASE; AMINO ACID SEQUENCE; CONVALESCENCE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HLA-A2 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

HEPATITIS B VIRUS;

EID: 0029838758     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1096-1104     Document Type: Article

References (30)

1. Penna, A. et al. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174, 1565-1570 (1991).
2. Bertoletti, A. et al. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88, 10445-10449 (1991).
3. Missale, G. et al. HLA-A31 and Aw68 restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177, 751-762 (1993).
4. Rehermann, B. et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181, 1047-1058 (1995).
5. Michalak, T.I., Pasquinelli, C., Guilhot, S. & Chisari, F.V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 93, 230-239 (1994).
6. Rehermann, B., Lau, D., Hoofnagle, J. & Chisari, F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 97, 1655-1665 (1996).
7. Nayersina, R. et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150, 4659-4671 (1993).
8. Scotto, J. et al. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results for other viral markers. Hepatology 3, 279-284 (1983).
9. Bonino, F. et al. Hepatitis B virus DNA in the sera of HBs Ag carriers: A marker of active hepatitis B virus replication in the liver. Hepatology 1, 386-391 (1981).
10. Mandel, T.E., Phipps, R.P., Abbot, A. & Tew, J.G. The follicular dendritic cell: Long term antigen retention during immunity. Immunol. Rev. 53, 29-57 (1980).
11. Tew, J.G., Kosko, M.H., Burton, G.F. & Szakal, A.K. Follicular dendritic cells as accessory cells. Immunol. Rev. 117, 185-211 (1990).
12. Sprent, J. T and B memory cells. Cell 76, 315-322 (1994).
13. Lau, L.L., Jamieson, B.D., Somasundaram, T. & Ahmed, R. Cytotoxic T cell memory without antigen. Nature 369, 648-652 (1994).
14. Oehen, S., Waldner, H.P., Kündig, T., Hengartner, H. & Zinkernagel, R.M. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med. 176, 1273-1281 (1992).
15. Muellbacher, A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J. Exp. Med. 179, 317-321 (1994).
16. + T-cell memory determined by clonal burst size. Nature 369, 652-654 (1994).
17. Demkowicz, W.E., Jr., Littaua, R.A., Wang, J. & Ennis, F.A. Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus. J. Virol. 70, 2627-2631 (1996).
18. Martin, B.A., Rowe, J.M., Kouides, P.A. & DiPersio, J.F. Hepatitis B reactivation following allogeneic bone marrow transplantation: Case report and review of the literature. Bone Marrow Transplant. 15, 145-148 (1995).
19. McIvor, C. et al. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann. Intern. Med. 121, 274-276 (1994).
20. Chazouilleres, O. et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 343, 142-146 (1994).
21. Preisler-Adams, S., Schlayer, H.-J., Peters, T., Hettler, F., Gerok, W. & Rasenack, J. Identification and sequence analysis of hepatitis B virus DNA in immunologically-negative infection. Arch. Virol. 133, 385-396 (1993).
22. Thiers, V. et al. Transmission of hepatitis B from hepatitis B-seronegative subjects. Lancet ii, 1273-1276 (1988).
23. Wachs, M.E. et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 59, 230-234 (1995).
24. Pasek, M. et al. Hepatitis B virus genes and their expression in E. coli. Nature 282, 575-579 (1979).
25. Chakrabarti, S., Brechling, K. & Moss, B. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant plaques. Mol. Cell. Biol. 5, 3403-3409 (1985).
26. Schlicht, H.J. & Schaller, H. The secretory core protein of human hepatitis B virus is expressed on the cell surface. J. Virol. 63, 5399-5404 (1989).
27. Guilhot, S. et al. Hepatitis B virus (HBV) specific cytolytic T cell response in humans: Production of target cells by stable expression of HBV-encoded proteins in immortalized human B cell lines. J. Virol. 66, 2670-2678 (1992).
28. Fazekas, S. & Groth, S.T. The evaluation of limiting dilution assays. J. Immunol. Methods 49, R11-R23 (1982).
29. Madsen, M. & Johnson, H.E. A methodological study of E-rosette formation using AET-treated sheep erythrocytes. J. Immunol. Methods 27, 61-74 (1979).
30. Gilles, P.N., Fey, G. & Chisari, F.V. Tumor necrosis factor-alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J. Virol. 66, 3955-3960 (1992).